TICH-3 trial — DEMO SITE
Tranexamic acid for IntraCerebral Haemorrhage 3


ISRCTN 97695350
Twitter
Room S/D2108, Stroke Trials Unit
School of Medicine, University of Nottingham
Queen's Medical Centre, Derby Road
Nottingham NG7 2UH, United Kingdom
Please log in if you need the TICH-3 emergency contact numbers. The recruitment total for the trial to date is: 53

Login using the investigator ID, password issued to you by the

TICH-3 investigator ID:
Password:

Please ensure that your web browser has both cookies and JavaScript enabled.

  • Serious Adverse Events (SAEs) — we have a legal responsibility to collect all safety events occurring within the first 7 days after randomisation (including SARs/SUSARs/fatal SAEs).
  • Safety events include: venous thromboembolism; ischaemic events (arterial thrombosis at any site, ischaemic stroke, transient ischaemic attack, peripheral artery embolism, myocardial infarction, acute coronary syndrome) and seizures.
  • Please remember that fatal SAEs need to be reported, even if after 7 days - unless death occurred after discharge from hospital.
  • Please assess if expected according to SmPC.  Expectedness should only be assessed in events that are thought to be possibly/probably/definitely related to the IMP.
  • Investigators have a legal responsibility to report applicable SAEs to the chief investigator without delay, within 24 hours.

Latest recruiting hospitals
Nottingham DEMO Hospital, NOTTINGHAM, UK
Ospedale di Desenzano, Desenzano del Garda (Bs), Italy
Derby TEST hospital, DERBY, UK
Leicester TEST Infirmary, Leicester, UK
Aberdeen TEST Infirmary, Aberdeen, UK
  
Average time to randomisation (last 6 months)
# Hours Hospital
1 0.9 Ospedale di Desenzano, Desenzano del Garda (Bs), Italy
6 3.4 Nottingham DEMO Hospital, NOTTINGHAM, UK